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Background:  Diabetes mellitus (DM) and chronic renal insufficiency (Renal) is increasing in incidence in patients undergoing superficial femoral 
artery (SFA) interventions. The synergistic influence is not well described. Outcomes of SFA interventions in such patients were examined.
Methods:  A database of SFA endovascular treatment (1999-2009) was queried. Patients were categorized as no DM or Renal, DM if insulin/non-
insulin dependent DM, Renal if glomerular filtration rate (eGFR) <60ml/min/1.73m3, and DM+Renal. Pre-operative angiograms were reviewed and 
scored (1 to 19 by modified SVS criteria) to assess distal runoff. Higher score implies worse runoff. Kaplan-Meier analyses assessed time-dependent 
outcomes. Factor analyses were performed (Cox model) for time dependent variables.
Results:  1018 limbs underwent SFA intervention for symptomatic disease. Patients with DM+Renal had greater rest pain, tissue loss, poorer 
runoff and worse level of ischemia. Mortality and morbidity was elevated in Renal group. Freedom from recurrent symptoms was worse in DM, Renal, 
and DM+Renal despite no difference in anatomic outcomes. Presence of DM+Renal resulted in decreased limb salvage that correlated with worse 
presenting symptoms and tibial runoff (Table). 
Control DM Renal DM+Renal
Number Limbs at Risk (n) 405 356 72 185
Gender (%) 67% 63% 65% 59%
Age (mean±SD) yrs 66±15 66±14 75±11** 66±13
Rest Pain / Tissue Loss (%) 27% 51%* 56%* 71%**
TransAtlantic InterSociety Consensus (TASC) C, D lesions (%) 40% 40% 40% 40%
Runoff Index (mean±SD) 5.6±4.3 6.9±4.6** 7.6±4.3** 7.9±4.1**
Mortality (%) 0.7 0.3 5.6 ** 0.0
Morbidity (%) 10.1 11.0 22.2** 8.5
5 year Freedom from Recurrent Symptoms (%) 74 65* 63* 60**
5 year Limb Salvage (%) 91 84 89 60**
5 year Primary Patency (%) 66 59 62 63
5 year Assisted Primary Patency (%) 78 80 72 75
5yr-Secondary Patency (%) 78 81 72 75
* p<0.05 and **p<0.01 compared to Control
Conclusion: Presence of DM+Renal is associated with decreased clinical efficacy after SFA intervention with poorer rates of symptom relief and 
lower limb salvage rate. This is driven by worse presenting symptoms and poor tibial runoff.
